Cephalosporins are potent SARS-CoV-2 main protease inhibitors.
- DOI
- 10.1016/j.ejmech.2026.118995
- Published
- 2026 Oct 15
- Container
- European journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejmech.2026.118995,
title = {Cephalosporins are potent SARS-CoV-2 main protease inhibitors.},
author = {Muntean DG and Treyde W and Laczi D and Laidlaw SM and Salah E and Choudhry H and Carroll MW and Duarte F and Schofield CJ and Brewitz L},
year = {2026},
journal = {European journal of medicinal chemistry},
doi = {10.1016/j.ejmech.2026.118995},
url = {https://doi.org/10.1016/j.ejmech.2026.118995}
}RIS
TY - JOUR TI - Cephalosporins are potent SARS-CoV-2 main protease inhibitors. AU - Muntean DG AU - Treyde W AU - Laczi D AU - Laidlaw SM AU - Salah E AU - Choudhry H AU - Carroll MW AU - Duarte F AU - Schofield CJ AU - Brewitz L PY - 2026 JO - European journal of medicinal chemistry DO - 10.1016/j.ejmech.2026.118995 UR - https://doi.org/10.1016/j.ejmech.2026.118995 ER -
APA
DG, M., W, T., D, L., SM, L., E, S., H, C., MW, C., F, D., CJ, S., & L, B. (2026). Cephalosporins are potent SARS-CoV-2 main protease inhibitors.. European journal of medicinal chemistry. https://doi.org/10.1016/j.ejmech.2026.118995
Source records
- pubmed · retrieved 2026-09-26T00:51:20.292Z
- europe-pmc · retrieved 2026-09-26T00:51:20.305Z